Review



human neuroblastoma cell lines chla255  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    ATCC human neuroblastoma cell lines chla255
    Human Neuroblastoma Cell Lines Chla255, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1088 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human neuroblastoma cell lines chla255/product/ATCC
    Average 97 stars, based on 1088 article reviews
    human neuroblastoma cell lines chla255 - by Bioz Stars, 2026-05
    97/100 stars

    Images



    Similar Products

    97
    ATCC human neuroblastoma cell lines chla255
    Human Neuroblastoma Cell Lines Chla255, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human neuroblastoma cell lines chla255/product/ATCC
    Average 97 stars, based on 1 article reviews
    human neuroblastoma cell lines chla255 - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    94
    CLS Cell Lines Service GmbH human megakaryocytes
    Human Megakaryocytes, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human megakaryocytes/product/CLS Cell Lines Service GmbH
    Average 94 stars, based on 1 article reviews
    human megakaryocytes - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    86
    Procell Inc human meg 01 cells
    Human Meg 01 Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human meg 01 cells/product/Procell Inc
    Average 86 stars, based on 1 article reviews
    human meg 01 cells - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    97
    ATCC human megakaryoblast meg 01 cells
    Human Megakaryoblast Meg 01 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human megakaryoblast meg 01 cells/product/ATCC
    Average 97 stars, based on 1 article reviews
    human megakaryoblast meg 01 cells - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    97
    ATCC human megakaryocytes in vitro cell line
    Silencing of CDK4 or CDK1 or Cyclin B1 in MEG-01 cells reduced DENV2 loads and enhanced CDK1 and Cyclin B1 interactions is enhanced upon DENV2 infection. QRT-PCR and immunoblotting analyses showing silencing of CDK4 ( A , D ) or CDK1 ( B , E ) or Cyclin B1 ( C , F ) in MEG-01 cells transfected with either scrambled siRNA or siRNA for respective genes (CDK4, CDK1, and Cyclin B1) for 24 h and followed by DENV2 infection (MOI of 5, at 24 h p.i.). QRT-PCR and immunoblotting analyses is shown for DENV2 capsid gene or protein loads determined upon silencing of CDK4 ( D , J ), or CDK1 ( H , K ) or Cyclin B1 ( I , L ) in MEG-01 cells transfected with either scrambled siRNA or siRNA for respective genes (CDK4, CDK1, and Cyclin B1) for 24 h and followed by DENV2 infection (MOI of 5, at 24 h p.i.). DENV2-loads and mRNA expression levels of CDK4, CDK1 and Cyclin B1 genes were normalized to human beta-actin mRNA levels. Y-axis represents levels of transcripts and X-axis indicates uninfected or DENV2-infected groups. P value determined by student’s t-test is shown. Scrambled siRNA-treated samples serve as negative control. ( M ) Immunoprecipitation assay performed with MEG-01 cell lysates from uninfected or DENV2-infected sample (MOI of 5, at 72 h p.i.) using Cyclin B1 antibody and detection with CDK1 antibody is shown for interaction between Cyclin B1 and CDK1 upon DENV2 infection. Total protein profile images serve as loading control (in panels D , E , F , J , K , L and M ). ( N ) Schematic representation shown as model to summarize the current findings. DENV2 enters megakaryocyte cells and upregulates CDK4 protein, which eventually may enter the nucleus and facilitate cell progression from G1 to S phase. DENV2 induces the expression of CDK1 and Cyclin B1 and their interactions that may further assist in the progression of <t>megakaryocytes</t> through the G2 phase of the cell cycle into mitosis. Once the megakaryocytes enter the metaphase, DENV2 may reduce the expression of certain molecules, which are inhibitory to the progression of anaphase A. As a result, DENV2 modulates the cell cycle process in megakaryocytes by pushing from one phase to the next and eventually creating a favorable environment for DENV2 to selectively replicate inside megakaryocytes that undergoes polyploidy and endomitosis.
    Human Megakaryocytes In Vitro Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human megakaryocytes in vitro cell line/product/ATCC
    Average 97 stars, based on 1 article reviews
    human megakaryocytes in vitro cell line - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    97
    ATCC dengue infection human megakaryocytes in vitro cell line
    Silencing of CDK4 or CDK1 or Cyclin B1 in MEG-01 cells reduced DENV2 loads and enhanced CDK1 and Cyclin B1 interactions is enhanced upon DENV2 infection. QRT-PCR and immunoblotting analyses showing silencing of CDK4 ( A , D ) or CDK1 ( B , E ) or Cyclin B1 ( C , F ) in MEG-01 cells transfected with either scrambled siRNA or siRNA for respective genes (CDK4, CDK1, and Cyclin B1) for 24 h and followed by DENV2 infection (MOI of 5, at 24 h p.i.). QRT-PCR and immunoblotting analyses is shown for DENV2 capsid gene or protein loads determined upon silencing of CDK4 ( D , J ), or CDK1 ( H , K ) or Cyclin B1 ( I , L ) in MEG-01 cells transfected with either scrambled siRNA or siRNA for respective genes (CDK4, CDK1, and Cyclin B1) for 24 h and followed by DENV2 infection (MOI of 5, at 24 h p.i.). DENV2-loads and mRNA expression levels of CDK4, CDK1 and Cyclin B1 genes were normalized to human beta-actin mRNA levels. Y-axis represents levels of transcripts and X-axis indicates uninfected or DENV2-infected groups. P value determined by student’s t-test is shown. Scrambled siRNA-treated samples serve as negative control. ( M ) Immunoprecipitation assay performed with MEG-01 cell lysates from uninfected or DENV2-infected sample (MOI of 5, at 72 h p.i.) using Cyclin B1 antibody and detection with CDK1 antibody is shown for interaction between Cyclin B1 and CDK1 upon DENV2 infection. Total protein profile images serve as loading control (in panels D , E , F , J , K , L and M ). ( N ) Schematic representation shown as model to summarize the current findings. DENV2 enters megakaryocyte cells and upregulates CDK4 protein, which eventually may enter the nucleus and facilitate cell progression from G1 to S phase. DENV2 induces the expression of CDK1 and Cyclin B1 and their interactions that may further assist in the progression of <t>megakaryocytes</t> through the G2 phase of the cell cycle into mitosis. Once the megakaryocytes enter the metaphase, DENV2 may reduce the expression of certain molecules, which are inhibitory to the progression of anaphase A. As a result, DENV2 modulates the cell cycle process in megakaryocytes by pushing from one phase to the next and eventually creating a favorable environment for DENV2 to selectively replicate inside megakaryocytes that undergoes polyploidy and endomitosis.
    Dengue Infection Human Megakaryocytes In Vitro Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dengue infection human megakaryocytes in vitro cell line/product/ATCC
    Average 97 stars, based on 1 article reviews
    dengue infection human megakaryocytes in vitro cell line - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    97
    ATCC human meg 01 cells
    Silencing of CDK4 or CDK1 or Cyclin B1 in MEG-01 cells reduced DENV2 loads and enhanced CDK1 and Cyclin B1 interactions is enhanced upon DENV2 infection. QRT-PCR and immunoblotting analyses showing silencing of CDK4 ( A , D ) or CDK1 ( B , E ) or Cyclin B1 ( C , F ) in MEG-01 cells transfected with either scrambled siRNA or siRNA for respective genes (CDK4, CDK1, and Cyclin B1) for 24 h and followed by DENV2 infection (MOI of 5, at 24 h p.i.). QRT-PCR and immunoblotting analyses is shown for DENV2 capsid gene or protein loads determined upon silencing of CDK4 ( D , J ), or CDK1 ( H , K ) or Cyclin B1 ( I , L ) in MEG-01 cells transfected with either scrambled siRNA or siRNA for respective genes (CDK4, CDK1, and Cyclin B1) for 24 h and followed by DENV2 infection (MOI of 5, at 24 h p.i.). DENV2-loads and mRNA expression levels of CDK4, CDK1 and Cyclin B1 genes were normalized to human beta-actin mRNA levels. Y-axis represents levels of transcripts and X-axis indicates uninfected or DENV2-infected groups. P value determined by student’s t-test is shown. Scrambled siRNA-treated samples serve as negative control. ( M ) Immunoprecipitation assay performed with MEG-01 cell lysates from uninfected or DENV2-infected sample (MOI of 5, at 72 h p.i.) using Cyclin B1 antibody and detection with CDK1 antibody is shown for interaction between Cyclin B1 and CDK1 upon DENV2 infection. Total protein profile images serve as loading control (in panels D , E , F , J , K , L and M ). ( N ) Schematic representation shown as model to summarize the current findings. DENV2 enters megakaryocyte cells and upregulates CDK4 protein, which eventually may enter the nucleus and facilitate cell progression from G1 to S phase. DENV2 induces the expression of CDK1 and Cyclin B1 and their interactions that may further assist in the progression of <t>megakaryocytes</t> through the G2 phase of the cell cycle into mitosis. Once the megakaryocytes enter the metaphase, DENV2 may reduce the expression of certain molecules, which are inhibitory to the progression of anaphase A. As a result, DENV2 modulates the cell cycle process in megakaryocytes by pushing from one phase to the next and eventually creating a favorable environment for DENV2 to selectively replicate inside megakaryocytes that undergoes polyploidy and endomitosis.
    Human Meg 01 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human meg 01 cells/product/ATCC
    Average 97 stars, based on 1 article reviews
    human meg 01 cells - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    97
    ATCC 309 human megakaryoblast meg 01 cells
    Silencing of CDK4 or CDK1 or Cyclin B1 in MEG-01 cells reduced DENV2 loads and enhanced CDK1 and Cyclin B1 interactions is enhanced upon DENV2 infection. QRT-PCR and immunoblotting analyses showing silencing of CDK4 ( A , D ) or CDK1 ( B , E ) or Cyclin B1 ( C , F ) in MEG-01 cells transfected with either scrambled siRNA or siRNA for respective genes (CDK4, CDK1, and Cyclin B1) for 24 h and followed by DENV2 infection (MOI of 5, at 24 h p.i.). QRT-PCR and immunoblotting analyses is shown for DENV2 capsid gene or protein loads determined upon silencing of CDK4 ( D , J ), or CDK1 ( H , K ) or Cyclin B1 ( I , L ) in MEG-01 cells transfected with either scrambled siRNA or siRNA for respective genes (CDK4, CDK1, and Cyclin B1) for 24 h and followed by DENV2 infection (MOI of 5, at 24 h p.i.). DENV2-loads and mRNA expression levels of CDK4, CDK1 and Cyclin B1 genes were normalized to human beta-actin mRNA levels. Y-axis represents levels of transcripts and X-axis indicates uninfected or DENV2-infected groups. P value determined by student’s t-test is shown. Scrambled siRNA-treated samples serve as negative control. ( M ) Immunoprecipitation assay performed with MEG-01 cell lysates from uninfected or DENV2-infected sample (MOI of 5, at 72 h p.i.) using Cyclin B1 antibody and detection with CDK1 antibody is shown for interaction between Cyclin B1 and CDK1 upon DENV2 infection. Total protein profile images serve as loading control (in panels D , E , F , J , K , L and M ). ( N ) Schematic representation shown as model to summarize the current findings. DENV2 enters megakaryocyte cells and upregulates CDK4 protein, which eventually may enter the nucleus and facilitate cell progression from G1 to S phase. DENV2 induces the expression of CDK1 and Cyclin B1 and their interactions that may further assist in the progression of <t>megakaryocytes</t> through the G2 phase of the cell cycle into mitosis. Once the megakaryocytes enter the metaphase, DENV2 may reduce the expression of certain molecules, which are inhibitory to the progression of anaphase A. As a result, DENV2 modulates the cell cycle process in megakaryocytes by pushing from one phase to the next and eventually creating a favorable environment for DENV2 to selectively replicate inside megakaryocytes that undergoes polyploidy and endomitosis.
    309 Human Megakaryoblast Meg 01 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/309 human megakaryoblast meg 01 cells/product/ATCC
    Average 97 stars, based on 1 article reviews
    309 human megakaryoblast meg 01 cells - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    97
    ATCC human megakaryocytic leukemia cell line
    Silencing of CDK4 or CDK1 or Cyclin B1 in MEG-01 cells reduced DENV2 loads and enhanced CDK1 and Cyclin B1 interactions is enhanced upon DENV2 infection. QRT-PCR and immunoblotting analyses showing silencing of CDK4 ( A , D ) or CDK1 ( B , E ) or Cyclin B1 ( C , F ) in MEG-01 cells transfected with either scrambled siRNA or siRNA for respective genes (CDK4, CDK1, and Cyclin B1) for 24 h and followed by DENV2 infection (MOI of 5, at 24 h p.i.). QRT-PCR and immunoblotting analyses is shown for DENV2 capsid gene or protein loads determined upon silencing of CDK4 ( D , J ), or CDK1 ( H , K ) or Cyclin B1 ( I , L ) in MEG-01 cells transfected with either scrambled siRNA or siRNA for respective genes (CDK4, CDK1, and Cyclin B1) for 24 h and followed by DENV2 infection (MOI of 5, at 24 h p.i.). DENV2-loads and mRNA expression levels of CDK4, CDK1 and Cyclin B1 genes were normalized to human beta-actin mRNA levels. Y-axis represents levels of transcripts and X-axis indicates uninfected or DENV2-infected groups. P value determined by student’s t-test is shown. Scrambled siRNA-treated samples serve as negative control. ( M ) Immunoprecipitation assay performed with MEG-01 cell lysates from uninfected or DENV2-infected sample (MOI of 5, at 72 h p.i.) using Cyclin B1 antibody and detection with CDK1 antibody is shown for interaction between Cyclin B1 and CDK1 upon DENV2 infection. Total protein profile images serve as loading control (in panels D , E , F , J , K , L and M ). ( N ) Schematic representation shown as model to summarize the current findings. DENV2 enters megakaryocyte cells and upregulates CDK4 protein, which eventually may enter the nucleus and facilitate cell progression from G1 to S phase. DENV2 induces the expression of CDK1 and Cyclin B1 and their interactions that may further assist in the progression of <t>megakaryocytes</t> through the G2 phase of the cell cycle into mitosis. Once the megakaryocytes enter the metaphase, DENV2 may reduce the expression of certain molecules, which are inhibitory to the progression of anaphase A. As a result, DENV2 modulates the cell cycle process in megakaryocytes by pushing from one phase to the next and eventually creating a favorable environment for DENV2 to selectively replicate inside megakaryocytes that undergoes polyploidy and endomitosis.
    Human Megakaryocytic Leukemia Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human megakaryocytic leukemia cell line/product/ATCC
    Average 97 stars, based on 1 article reviews
    human megakaryocytic leukemia cell line - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    97
    ATCC human myeloid leukemic cells
    Silencing of CDK4 or CDK1 or Cyclin B1 in MEG-01 cells reduced DENV2 loads and enhanced CDK1 and Cyclin B1 interactions is enhanced upon DENV2 infection. QRT-PCR and immunoblotting analyses showing silencing of CDK4 ( A , D ) or CDK1 ( B , E ) or Cyclin B1 ( C , F ) in MEG-01 cells transfected with either scrambled siRNA or siRNA for respective genes (CDK4, CDK1, and Cyclin B1) for 24 h and followed by DENV2 infection (MOI of 5, at 24 h p.i.). QRT-PCR and immunoblotting analyses is shown for DENV2 capsid gene or protein loads determined upon silencing of CDK4 ( D , J ), or CDK1 ( H , K ) or Cyclin B1 ( I , L ) in MEG-01 cells transfected with either scrambled siRNA or siRNA for respective genes (CDK4, CDK1, and Cyclin B1) for 24 h and followed by DENV2 infection (MOI of 5, at 24 h p.i.). DENV2-loads and mRNA expression levels of CDK4, CDK1 and Cyclin B1 genes were normalized to human beta-actin mRNA levels. Y-axis represents levels of transcripts and X-axis indicates uninfected or DENV2-infected groups. P value determined by student’s t-test is shown. Scrambled siRNA-treated samples serve as negative control. ( M ) Immunoprecipitation assay performed with MEG-01 cell lysates from uninfected or DENV2-infected sample (MOI of 5, at 72 h p.i.) using Cyclin B1 antibody and detection with CDK1 antibody is shown for interaction between Cyclin B1 and CDK1 upon DENV2 infection. Total protein profile images serve as loading control (in panels D , E , F , J , K , L and M ). ( N ) Schematic representation shown as model to summarize the current findings. DENV2 enters megakaryocyte cells and upregulates CDK4 protein, which eventually may enter the nucleus and facilitate cell progression from G1 to S phase. DENV2 induces the expression of CDK1 and Cyclin B1 and their interactions that may further assist in the progression of <t>megakaryocytes</t> through the G2 phase of the cell cycle into mitosis. Once the megakaryocytes enter the metaphase, DENV2 may reduce the expression of certain molecules, which are inhibitory to the progression of anaphase A. As a result, DENV2 modulates the cell cycle process in megakaryocytes by pushing from one phase to the next and eventually creating a favorable environment for DENV2 to selectively replicate inside megakaryocytes that undergoes polyploidy and endomitosis.
    Human Myeloid Leukemic Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human myeloid leukemic cells/product/ATCC
    Average 97 stars, based on 1 article reviews
    human myeloid leukemic cells - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    Image Search Results


    Silencing of CDK4 or CDK1 or Cyclin B1 in MEG-01 cells reduced DENV2 loads and enhanced CDK1 and Cyclin B1 interactions is enhanced upon DENV2 infection. QRT-PCR and immunoblotting analyses showing silencing of CDK4 ( A , D ) or CDK1 ( B , E ) or Cyclin B1 ( C , F ) in MEG-01 cells transfected with either scrambled siRNA or siRNA for respective genes (CDK4, CDK1, and Cyclin B1) for 24 h and followed by DENV2 infection (MOI of 5, at 24 h p.i.). QRT-PCR and immunoblotting analyses is shown for DENV2 capsid gene or protein loads determined upon silencing of CDK4 ( D , J ), or CDK1 ( H , K ) or Cyclin B1 ( I , L ) in MEG-01 cells transfected with either scrambled siRNA or siRNA for respective genes (CDK4, CDK1, and Cyclin B1) for 24 h and followed by DENV2 infection (MOI of 5, at 24 h p.i.). DENV2-loads and mRNA expression levels of CDK4, CDK1 and Cyclin B1 genes were normalized to human beta-actin mRNA levels. Y-axis represents levels of transcripts and X-axis indicates uninfected or DENV2-infected groups. P value determined by student’s t-test is shown. Scrambled siRNA-treated samples serve as negative control. ( M ) Immunoprecipitation assay performed with MEG-01 cell lysates from uninfected or DENV2-infected sample (MOI of 5, at 72 h p.i.) using Cyclin B1 antibody and detection with CDK1 antibody is shown for interaction between Cyclin B1 and CDK1 upon DENV2 infection. Total protein profile images serve as loading control (in panels D , E , F , J , K , L and M ). ( N ) Schematic representation shown as model to summarize the current findings. DENV2 enters megakaryocyte cells and upregulates CDK4 protein, which eventually may enter the nucleus and facilitate cell progression from G1 to S phase. DENV2 induces the expression of CDK1 and Cyclin B1 and their interactions that may further assist in the progression of megakaryocytes through the G2 phase of the cell cycle into mitosis. Once the megakaryocytes enter the metaphase, DENV2 may reduce the expression of certain molecules, which are inhibitory to the progression of anaphase A. As a result, DENV2 modulates the cell cycle process in megakaryocytes by pushing from one phase to the next and eventually creating a favorable environment for DENV2 to selectively replicate inside megakaryocytes that undergoes polyploidy and endomitosis.

    Journal: Scientific Reports

    Article Title: Dengue virus modulates critical cell cycle regulatory proteins in human megakaryocyte cells

    doi: 10.1038/s41598-025-02640-5

    Figure Lengend Snippet: Silencing of CDK4 or CDK1 or Cyclin B1 in MEG-01 cells reduced DENV2 loads and enhanced CDK1 and Cyclin B1 interactions is enhanced upon DENV2 infection. QRT-PCR and immunoblotting analyses showing silencing of CDK4 ( A , D ) or CDK1 ( B , E ) or Cyclin B1 ( C , F ) in MEG-01 cells transfected with either scrambled siRNA or siRNA for respective genes (CDK4, CDK1, and Cyclin B1) for 24 h and followed by DENV2 infection (MOI of 5, at 24 h p.i.). QRT-PCR and immunoblotting analyses is shown for DENV2 capsid gene or protein loads determined upon silencing of CDK4 ( D , J ), or CDK1 ( H , K ) or Cyclin B1 ( I , L ) in MEG-01 cells transfected with either scrambled siRNA or siRNA for respective genes (CDK4, CDK1, and Cyclin B1) for 24 h and followed by DENV2 infection (MOI of 5, at 24 h p.i.). DENV2-loads and mRNA expression levels of CDK4, CDK1 and Cyclin B1 genes were normalized to human beta-actin mRNA levels. Y-axis represents levels of transcripts and X-axis indicates uninfected or DENV2-infected groups. P value determined by student’s t-test is shown. Scrambled siRNA-treated samples serve as negative control. ( M ) Immunoprecipitation assay performed with MEG-01 cell lysates from uninfected or DENV2-infected sample (MOI of 5, at 72 h p.i.) using Cyclin B1 antibody and detection with CDK1 antibody is shown for interaction between Cyclin B1 and CDK1 upon DENV2 infection. Total protein profile images serve as loading control (in panels D , E , F , J , K , L and M ). ( N ) Schematic representation shown as model to summarize the current findings. DENV2 enters megakaryocyte cells and upregulates CDK4 protein, which eventually may enter the nucleus and facilitate cell progression from G1 to S phase. DENV2 induces the expression of CDK1 and Cyclin B1 and their interactions that may further assist in the progression of megakaryocytes through the G2 phase of the cell cycle into mitosis. Once the megakaryocytes enter the metaphase, DENV2 may reduce the expression of certain molecules, which are inhibitory to the progression of anaphase A. As a result, DENV2 modulates the cell cycle process in megakaryocytes by pushing from one phase to the next and eventually creating a favorable environment for DENV2 to selectively replicate inside megakaryocytes that undergoes polyploidy and endomitosis.

    Article Snippet: Human megakaryocytes in vitro cell line (MEG-01 cells derived from bone marrow of a leukemic patient, catalog number CRL-2021) or human endothelial cells (EA.hy926, catalog number CRL-2922) were obtained from American Type Culture Collection (ATCC).

    Techniques: Infection, Quantitative RT-PCR, Western Blot, Transfection, Expressing, Negative Control, Immunoprecipitation, Control